ImmunoPrecise Sets Third Quarter Fiscal 2022 Financial Results and Recent Business Highlights Conference Call for Wednesday, March 16th at 10:30 a.m. ET

Rhea-AI Summary

ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA) announced a conference call scheduled for March 16, 2022, at 10:30 a.m. ET, to discuss its third quarter fiscal year 2022 financial results and recent business highlights. The company will issue a press release before the call, and management will host a question-and-answer session. Investors can submit their questions to John Mullaly of LifeSci Advisors. The call will be available via webcast and can be accessed from the company's investor relations website.

Positive

• Upcoming conference call for Q3 2022 results indicates proactive communication with investors.

Negative

• None.

VICTORIA, British Columbia--(BUSINESS WIRE)-- IMMUNOPRECISE ANTIBODIES LTD. (the "Company" or "IPA") (NASDAQ: IPA) (TSX VENTURE: IPA) a leader in full-service, therapeutic antibody discovery and development, today announced today announced that it will host a conference call to discuss its financial results and recent business highlights for third quarter fiscal year 2022, on Wednesday, March 16^th, 2022, at 10:30 a.m. ET. The financial results will be issued in a press release prior to the call. ImmunoPrecise management will host the conference call followed by a pre-submitted question-and-answer period.

Investors interested in submitting questions ahead of the call are encouraged to email John Mullaly of LifeSci Advisors, the Company’s investor relations contact.

Earnings Call Details:

Date: March 16, 2022
Time: 10:30 a.m. Eastern time
Toll-free dial-in number: 1-877-407-3982
International dial-in number: 1-201-493-6780
Conference ID: 13727621
Webcast: https://viavid.webcasts.com/starthere.jsp?ei=1534157&tp_key=1be5e34d32
The conference call will be webcast live and available for replay via a link provided in the Investors section of the company’s website at https://www.immunoprecise.com/investors/.

Please call the conference telephone number five minutes prior to the start time. An operator will register your name and organization.

Anyone listening to the call is encouraged to read the company's periodic reports on file with the Toronto Stock Exchange and Securities and Exchange Commission, including the discussion of risk factors and historical results of operations and financial condition in those reports.

ImmunoPrecise Antibodies Ltd.
ImmunoPrecise is an innovation-driven technology platform company that supports its business partners in their quest to discover and develop novel antibodies against a broad range of classes of disease targets. The Company aims to transform the conventional multi-vendor antibody discovery model by providing a comprehensive suite of services tailored to optimize antibody genetic diversity and epitope coverage, to discover antibodies against rare and/or challenging epitopes. For further information, visit www.immunoprecise.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220308005501/en/

Investors:

LifeSci Advisors

John Mullaly

jmullaly@lifesciadvisors.com

Source: ImmunoPrecise Antibodies Ltd.

FAQ

When will ImmunoPrecise Antibodies release its Q3 2022 financial results?

The financial results will be announced before the conference call on March 16, 2022.

What time is the ImmunoPrecise Antibodies Q3 2022 results call?

The conference call is scheduled for 10:30 a.m. ET on March 16, 2022.

How can I listen to the ImmunoPrecise Antibodies earnings call?

The call will be accessible via a live webcast on the company's investor relations website.

Who can investors contact for questions regarding the earnings call?

Investors can email John Mullaly of LifeSci Advisors at jmullaly@lifesciadvisors.com.